Search Results
Feb 25, 2026, 10:00 ET An InventHelp 123Invent Client Develops 100 Yards Game (ADA-165)
to create an exciting new board game that would combine elements of dice/craps with football," said an inventor, from Redan, Ga., "so I invented the l00 YARDS. My design could spark added fun and friendly competition on game night or anytime."
More news about: InventHelp
Feb 25, 2026, 10:00 ET Georgia Trust for Historic Preservation Announces Its 2026 List of State's 10 Places in Peril
threaten these rare historic resources without comprehensive stabilization and restoration.Thomas L. Bell Memorial Ballpark, Americus (Sumter County)Opened in 1938, Thomas L. Bell Memorial Ballpark is a rare WPA-era wooden baseball stadium and a longtime center of sports and community
More news about: The Georgia Trust for Historic Preservation
Feb 25, 2026, 09:00 ET Invesco Advances Its Fixed Income ETF Lineup with Launch of Four New Funds
investments will be influenced by changes in exchange rates.Invesco Distributors, Inc. 02/26 NA 5239989NOT A DEPOSIT l NOT FDIC INSURED l NOT GUARANTEED BY THE BANK | MAY LOSE VALUE | NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCYContact: Samantha Brandifino,
More news about: Invesco Ltd.
Feb 25, 2026, 08:56 ET NoMIS Power Expands Medium-Voltage SiC MOSFET Portfolio with New 3.3 kV and 1.7 kV Devices
MOSFETs: NoMIS N3PT035MP330K (3.3 kV, 35 mΩ, 88 A) and NoMIS N3PT100MP170K (1.7 kV, 100 mΩ, 24 A). Both devices can be sampled as TO-247-4L packaged parts or as bare die. These releases underscore NoMIS Power's continued expansion toward higher-voltage and higher-current
More news about: NoMIS Power Corporation
Feb 25, 2026, 08:10 ET VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution
17;13(1):102. doi: 10.1186/s13613-023-01204-y.Morimont, L., et al. (2022). NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study. Biomolecules, 12(8), 1038.
More news about: VolitionRx Limited
Feb 25, 2026, 08:02 ET Archer Meat Snacks Secures Nearly $100 Million Credit Facility from J.P. Morgan
Snacks, 24-Weeks Ending 11/30/25ii SPINS, MULO + Natural, SS Jerky and Meat Snacks, 24-Weeks Ending 11/30/25iii L12W ending 6/15/2025 in MULO
More news about: Archer
Feb 25, 2026, 08:00 ET Contango Ore Intersects 60.22 g/t Gold over 5.92 meters, including 294.77 g/t Gold over 1.16 meters from Underground Drilling Program at the Lucky Shot Project, Alaska, USA
Au (L2 vein)LSU25032: 8.22 m averaging 2.92 g/t Au (L2 vein)LSU25036: 1.90 m averaging 8.29 g/t Au (KM vein)LSU25039: 5.28 m averaging 5.45 g/t Au (L1c vein)LSU25041: 0.50 m averaging 82.33 g/t Au (L1c vein)LSU25042: 1.06
More news about: Contango Ore
Feb 25, 2026, 08:00 ET TMYTEK and Metanoia Announce Strategic Collaboration on 5G FR2 gNB Solutions at MWC Barcelona
Communications.Visitors can learn more about TMYTEK's FR2 AiP portfolio at TMYTEK Hall 5 Booth #5J93, or Metanoia meeting rooms 5L24MR, 5L26MRAbout TMYTEKTMY Technology, Inc. (TMYTEK) is a global leader in mmWave innovation, offering advanced solutions for research,
More news about: TMYTEK
Feb 25, 2026, 08:00 ET Federal Signal Completes Record Year with Fourth Quarter Results including 27% Net Sales Growth, 19% Operating Income Increase, Record Quarterly Orders, and Strong Cash Generation; Issues 2026 Outlook
fourth-quarter performance represented a strong finish to a year in which we delivered the highest net sales and adjusted EPS in our history," commented Jennifer L. Sherman, President and Chief Executive Officer. "Our results included fourth-quarter records across consolidated net sales, adjusted EPS, and adjusted
More news about: Federal Signal Corporation
Feb 25, 2026, 07:26 ET SANY presentará nuevas máquinas, tecnología inteligente y servicios en CONEXPO 2026
amplios reposabrazos, lo que proporciona una experiencia de operación premium.Excavadora mediana SY335LC: Impulsada por un motor Cummins de 9 L y 209 kW, ofrece un par motor más potente y una cilindrada superior a la de su clase. Con 204 kN de fuerza en el cucharón y 153 kN de fuerza en el brazo,
More news about: SANY Group
Feb 25, 2026, 07:18 ET Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis
IL-36 are dominant cytokines in generalized pustular psoriasis. Journal of Allergy and Clinical Immunology 140(1), 109–120 (2017).Sachen, K. L. et al. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions. Cytokine 156, 155897 (2022).Prinz, J. C. et al. Prevalence,
More news about: Vanda Pharmaceuticals Inc.
Feb 25, 2026, 07:05 ET Allegheny Health Network Releases Most Popular Baby Names of 2025
celebration of all the beautiful babies born across Allegheny Health Network, and we also take this special moment to recognize and applaud the hundreds of L&D clinicians who deliver remarkable patient experiences daily," said
More news about: Allegheny Health Network
Feb 25, 2026, 07:00 ET Innoviz Reports Fourth Quarter and Full Year 2025 Results
over year, with record gross marginsSelected by Daimler Truck and Torc Robotics for series production of L4 Class 8 autonomous trucks, ongoing progress in L3 and L4 automotive programs with Mobileye, VW and othersIntroduced InnovizThree for behind-the-windshield deployment,
More news about: Innoviz Technologies Ltd
Feb 25, 2026, 07:00 ET Top 20 Broker Ryan Transportation Partners with Bot Auto for Full Driverless Operations in Texas
contact [email protected] Bot AutoBot Auto is an L4 autonomous trucking company offering Transportation as a Service (TaaS) through its AI-driven fleet. Combining visionary leadership, world-class engineering
More news about: Bot Auto TX, Inc
Feb 25, 2026, 04:43 ET SANY to Unveil New Machines, Smart Technology, and Service at CONEXPO 2026
full‑hydraulic load‑sensing system, suspension seat and wide armrests, delivering a premium operating experience.SY335LC Medium Excavator: Powered by a 9L, 209 kW Cummins engine, delivering stronger torque and higher displacement in its class. With 204 kN of bucket force and 153 kN of arm force, it delivers
More news about: SANY Group
Feb 25, 2026, 04:34 ET SANY to Unveil New Machines, Smart Technology, and Service at CONEXPO 2026
full‑hydraulic load‑sensing system, suspension seat and wide armrests, delivering a premium operating experience.SY335LC Medium Excavator: Powered by a 9L, 209 kW Cummins engine, delivering stronger torque and higher displacement in its class. With 204 kN of bucket force and 153 kN of arm force, it delivers
More news about: SANY Group
Feb 25, 2026, 03:00 ET Rapport 2026 de Group-IB sur les tendances de la criminalité liée à la haute technologie : les attaques contre la chaîne d'approvisionnement apparaissent comme la principale cybermenace mondiale
e-liee-a-la-haute-technologie--les-attaques-contre-la-chaine-dapprovisionnement-apparaissent-comme-la-principale-cybermenace-mondiale-302696685.html
More news about: Group-IB
Feb 24, 2026, 19:30 ET Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)
cell-surface PD-1. In a poster presented at ESMO Asia 2025, JS207 monotherapy showed encouraging efficacy across solid tumors. 62 patients with PD-L1 positive NSCLC received JS207 monotherapy as first-line treatment, and achieved an ORR of 58.1% and a DCR of 87.1%. Clinical activity has also
More news about: Antengene Corporation Limited
Feb 24, 2026, 18:20 ET TDS and Array to present at Raymond James 47th Annual Institutional Investors Conference
present at the Raymond James 47th Annual Institutional Investors Conference in Orlando, Fla. on March 3, 2026, at 10:25 a.m. ET. Vicki L. Villacrez, Executive Vice President and Chief Financial Officer, and Kris Bothfeld, Vice President of Financial Analysis and Strategic Planning, of TDS
More news about: Telephone and Data Systems, Inc. and Array Digital Infrastructure, Inc.
Feb 24, 2026, 17:04 ET National Event Series "Parkinson's IQ + You" Arrives in Southern Nevada to Educate and Empower Parkinson's Disease Patients and Care Partners
movement disorder specialist at Keck Medicine of USC; Dr. Katie Nathan, physical therapist at Moved by Movement; and speech language pathologist, Linda L. Ganz, MS, CCC-SLP at the Vegas Voice Institute. "Exploring the Latest in Parkinson's Research," led by Maggie Kuhl,
More news about: The Michael J. Fox Foundation for Parkinson's Research
Feb 24, 2026, 17:01 ET e& genera ingresos y ganancias netas récord en el año fiscal 2025
2025, aumentando los ingresos consolidados un 23% a 72.900 millones de AEDLa utilidad neta consolidada alcanzó los 14.400l millones de AED, creciendo un 34 % año tras año.La base de suscriptores de e& aumentó a 244,7 millones en Asia, África, Medio Oriente,
More news about: e&
Feb 24, 2026, 16:23 ET Caribbean Calling: Puerto Rican Pride Shines with Historic Opening of First Ideal Church of Scientology in the Islands
your new Ideal Church of Scientology of Puerto Rico!"This storied island has always held a treasured place in the life of Scientology Founder L. Ron Hubbard, who affectionately called it "my dearest island." In 1932, Mr. Hubbard arrived to lead its first complete mineral survey under U.S. jurisdiction,
More news about: Church of Scientology International
Feb 24, 2026, 16:15 ET Unisys Announces 4Q and Full-Year 2025 Results
adoption and innovation, TCV and Ex-L&S New Business TCV, the impact of new logo signings, backlog, book-to-bill(4), full-year 2026 revenue growth and profitability guidance, including constant currency revenue, Ex-L&S constant currency revenue growth, L&S revenue, non-GAAP operating
More news about: Unisys Corporation
Feb 24, 2026, 16:15 ET EOG Resources Reports Fourth Quarter and Full-Year 2025 Results; Announces 2026 Capital Plan
Drillbit Exploration and Development Expenditures (Non-GAAP) - (l)5,642
More news about: EOG Resources, Inc.
Feb 24, 2026, 16:05 ET Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
Practice-changing Phase 3 HERIZON-GEA-01 results support zanidatamab as the HER2-targeted agent of choice in HER2+ 1L gastroesophageal adenocarcinoma (GEA), regardless of PD-L1 status.Multiple registrational trials of zanidatamab are underway, including in metastatic breast cancer (mBC),
More news about: Jazz Pharmaceuticals plc